Skip to main content
. 2017 Apr 5;8(21):34946–34953. doi: 10.18632/oncotarget.16858

Figure 3. The preferred definitive radiotherapy dose for non-operable, thoracic esophageal squamous cell carcinoma (ESCC).

Figure 3